drugset / Trial / NCT01885156

Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris

NCT01885156

Phase 3 Completed 65 enrolled Merz North America, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To see how well Naftin 1% cream works when applied once daily to the affected area. The results will be compared to those using a placebo cream, which is a cream with no active ingredient. Safety will also be measured.

Timeline

Start
2013-08
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Naftifine Other / unclassified 1 % Topical